PMYZX
Price
$51.92
Change
-$0.41 (-0.78%)
Updated
Jul 13 closing price
Net Assets
6.29B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

PMYZX vs VSTSX

PMYZX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
PMYZX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMYZX is a StrongBuy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. PMYZX (6.29B). VSTSX pays higher dividends than PMYZX: VSTSX (1.07) vs PMYZX (0.67). PMYZX was incepted earlier than VSTSX: PMYZX (16 years) vs VSTSX (10 years). PMYZX (1.20) is less costly to investors than VSTSX (0.01). PMYZX is a more actively managed with annual turnover of: 13.00 vs. VSTSX (3.00). PMYZX has a lower initial minimum investment than VSTSX: PMYZX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. PMYZX (17.96). VSTSX return over 5 years is better than : 66.56 vs. PMYZX (48.06).
PMYZXVSTSXPMYZX / VSTSX
Total Expense Ratio1.200.0112,000%
Annual Report Gross Expense Ratio1.200.0112,000%
Fund Existence16 years10 years-
Gain YTD8.41111.20575%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.29B2.3T0%
Annual Yield % from dividends0.671.0762%
Returns for 1 year17.9621.4884%
Returns for 3 years59.1367.0688%
Returns for 5 years48.0666.5672%
Returns for 10 years215.26239.5390%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I